Switch theme
Sign up to access all valuation multiples
Coltene Holding AG is a Switzerland based company engaged in developing, manufacturing, and selling a range of disposables and tools for dentists and dental laboratories. The company divides its comprehensive product range into categories such as Infection Control, Dental Preservation, and Efficient Treatment categories. It offers products like aspirator tips, high-performance rotary instruments, dental dams and root canal instruments among others. The firm has its geographic presence in EMEA, North America, Latin America, and Asia/Oceania regions.
2005
1.2K+
LTM Revenue $305M
LTM EBITDA $42.2M
$501M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Coltene has a last 12-month revenue (LTM) of $305M and a last 12-month EBITDA of $42.2M.
In the most recent fiscal year, Coltene achieved revenue of $300M and an EBITDA of $41.1M.
Coltene expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Coltene valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $305M | XXX | $300M | XXX | XXX | XXX |
| Gross Profit | $200M | XXX | $188M | XXX | XXX | XXX |
| Gross Margin | 65% | XXX | 63% | XXX | XXX | XXX |
| EBITDA | $42.2M | XXX | $41.1M | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBIT | $33.7M | XXX | $32.2M | XXX | XXX | XXX |
| EBIT Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| Net Profit | $25.6M | XXX | $24.6M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $21.8M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Coltene's stock price is CHF 67 (or $80).
Coltene has current market cap of CHF 399M (or $479M), and EV of CHF 417M (or $501M).
See Coltene trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $501M | $479M | XXX | XXX | XXX | XXX | $4.32 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Coltene has market cap of $479M and EV of $501M.
Coltene's trades at 1.7x EV/Revenue multiple, and 12.2x EV/EBITDA.
Equity research analysts estimate Coltene's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Coltene has a P/E ratio of 18.8x.
See valuation multiples for Coltene and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $479M | XXX | $479M | XXX | XXX | XXX |
| EV (current) | $501M | XXX | $501M | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 11.9x | XXX | 12.2x | XXX | XXX | XXX |
| EV/EBIT | 14.9x | XXX | 15.5x | XXX | XXX | XXX |
| EV/Gross Profit | 2.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | 18.8x | XXX | 19.5x | XXX | XXX | XXX |
| EV/FCF | 23.8x | XXX | 18.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialColtene's last 12 month revenue growth is 3%
Coltene's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Coltene's rule of 40 is 13% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Coltene's rule of X is 22% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Coltene and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 25% | XXX | XXX | XXX |
| Rule of 40 | 13% | XXX | 17% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 22% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 52% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Coltene acquired XXX companies to date.
Last acquisition by Coltene was XXXXXXXX, XXXXX XXXXX XXXXXX . Coltene acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Coltene founded? | Coltene was founded in 2005. |
| Where is Coltene headquartered? | Coltene is headquartered in Switzerland. |
| How many employees does Coltene have? | As of today, Coltene has 1.2K+ employees. |
| Is Coltene publicy listed? | Yes, Coltene is a public company listed on SWX. |
| What is the stock symbol of Coltene? | Coltene trades under CLTN ticker. |
| When did Coltene go public? | Coltene went public in 2006. |
| Who are competitors of Coltene? | Similar companies to Coltene include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Coltene? | Coltene's current market cap is $479M |
| What is the current revenue of Coltene? | Coltene's last 12 months revenue is $305M. |
| What is the current revenue growth of Coltene? | Coltene revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Coltene? | Current revenue multiple of Coltene is 1.6x. |
| Is Coltene profitable? | Yes, Coltene is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Coltene? | Coltene's last 12 months EBITDA is $42.2M. |
| What is Coltene's EBITDA margin? | Coltene's last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of Coltene? | Current EBITDA multiple of Coltene is 11.9x. |
| What is the current FCF of Coltene? | Coltene's last 12 months FCF is $21.1M. |
| What is Coltene's FCF margin? | Coltene's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Coltene? | Current FCF multiple of Coltene is 23.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
